Imperative Care Launches Zoom 4S Thrombectomy Catheter

Imperative Care has launched and announced the first patient cases with its new Zoom 4S catheter, an advanced aspiration thrombectomy device for ischemic stroke treatment.

The Zoom 4S catheter was designed to navigate a wide variety of patient anatomies. It brings the ADAPT 2.0 technique to stoke patients, strengthening the company’s aim at systemization of stroke treatment. The system was engineered to simplify stroke thrombectomy procedures by reducing the number of device exchanges.

The ADAPT 2.0 technique was created to bring an intracranial 0.088” catheter closer to the clot, with aspiration through an asymmetric tip catheter for more complete clot ingestion. Enhanced power of aspiration is provided through Continuous Dual AspiraTion (CDAT) applied to two catheters.

The original ADAPT technique transformed stroke thrombectomy by showing the clinical value of direct aspiration as a frontline treatment to achieve excellent clinical and angiographic outcomes.

“At Imperative Care, we believe that it is our responsibility to bring the most advanced technologies to market, with the goal of improving patient outcomes by shaping the arc of innovation in stroke care,” said Richard Leparmentier, chief technology officer of Imperative Care. “With a focus on reducing treatment times and streamlining stroke procedures, we have purposefully engineered one simple Zoom setup to bring the key procedural benefits of the ADAPT 2.0 technique to more patients. With the introduction of Zoom 4S, Imperative Care is heralding this new chapter of stroke care, as we believe this combination of technologies will provide physicians with the confidence to effectively address a broad range of clot locations using a single setup.”

In October, the company shared positive efficacy and safety results from the pivotal SYMPHONY-PE Trial, which evaluated the company’s Symphony Thrombectomy System for acute pulmonary embolism (PE) treatment.